The COVID‐19 pandemic has necessitated rapid changes in healthcare delivery. Historically, uptake of virtual health care (VH) has been low, especially in specialized clinics; for example, 0.5% of all billable services were provided virtually in Canada in 2015. 1  Prior to March 2020, fewer than 5% of all patient visits in our clinic were by VH utilizing our health authority's approved platform; however, this platform required the patient to attend a remote healthcare facility, clearly undesirable during the pandemic. We trialed various platforms including FaceTime® and Zoom®. Barriers existed with both platforms such as specific device requirements, poor technology literacy, and/or privacy concerns. Ultimately, our clinic adopted a web‐based platform (Doxy.me®) that allows for videoconferencing with end‐to‐end encryption between healthcare provider (HCP) and patient. Over the span of 2 weeks, our clinic transitioned to providing more than 90% of patient care utilizing VH, while maintaining usual clinic capacity of approximately 10 post‐transplant patient visits per day. Patients transplanted within the previous 3 months and patients with unstable respiratory symptoms were prioritized for in‐person visits.